Total Payments
$51,581
2024 Payments
$8,870
Companies
15
Transactions
99
Payment Breakdown by Category
Other$41,593 (80.6%)
Consulting$3,443 (6.7%)
Travel$3,372 (6.5%)
Food & Beverage$3,173 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,593 | 35 | 76.8% |
| Consulting Fee | $3,443 | 1 | 6.7% |
| Travel and Lodging | $3,372 | 8 | 6.5% |
| Food and Beverage | $3,173 | 54 | 6.2% |
| Honoraria | $2,000 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $39,435 | 51 | $0 (2024) |
| Ascendis Pharma Inc | $5,842 | 7 | $0 (2024) |
| Dexcom, Inc. | $3,258 | 2 | $0 (2019) |
| Tandem Diabetes Care, Inc. | $1,925 | 8 | $0 (2020) |
| VYNE Pharmaceuticals Inc. | $306.92 | 17 | $0 (2021) |
| Medtronic MiniMed, Inc. | $262.20 | 2 | $0 (2019) |
| Insulet Corporation | $183.43 | 3 | $0 (2022) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| BETA BIONICS, INC. | $108.08 | 1 | $0 (2024) |
| Lilly USA, LLC | $42.38 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,870 | 9 | Ascendis Pharma Inc ($5,717) |
| 2023 | $3,527 | 6 | Novo Nordisk Inc ($3,509) |
| 2022 | $4,042 | 8 | Novo Nordisk Inc ($3,818) |
| 2021 | $4,338 | 12 | Novo Nordisk Inc ($4,195) |
| 2020 | $4,712 | 17 | Novo Nordisk Inc ($4,394) |
| 2019 | $7,580 | 13 | Novo Nordisk Inc ($3,988) |
| 2018 | $9,289 | 17 | Novo Nordisk Inc ($8,535) |
| 2017 | $9,222 | 17 | Novo Nordisk Inc ($7,951) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Growth Hormone | ||||||
| 11/14/2024 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,885.00 | General |
| Category: Growth Hormone | ||||||
| 10/02/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Endocrinology | ||||||
| 09/28/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Travel and Lodging | Cash or cash equivalent | $856.42 | General |
| Category: Endocrinology | ||||||
| 09/27/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $108.08 | General |
| Category: Automated insulin delivery system | ||||||
| 07/31/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Endocrinology | ||||||
| 07/27/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: Endocrinology | ||||||
| 06/12/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,003.00 | General |
| Category: Endocrinology | ||||||
| 11/01/2023 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Growth Hormone | ||||||
| 11/01/2023 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $61.75 | General |
| Category: Growth Hormone | ||||||
| 09/21/2023 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,885.00 | General |
| Category: Growth Hormone | ||||||
| 09/21/2023 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $93.76 | General |
| Category: Growth Hormone | ||||||
| 08/04/2023 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $308.75 | General |
| Category: Growth Hormone | ||||||
| 05/30/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2022 | Ascendis Pharma, Inc. | SKYTROFA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 11/17/2022 | Novo Nordisk Inc | Norditropin (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,755.00 | General |
| Category: Growth Hormone | ||||||
| 11/17/2022 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $116.19 | General |
| Category: Growth Hormone | ||||||
| 11/10/2022 | Novo Nordisk Inc | Norditropin (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,755.00 | General |
| Category: Growth Hormone | ||||||
| 11/10/2022 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: Growth Hormone | ||||||
| 11/02/2022 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $69.62 | General |
| Category: Growth Hormone | ||||||
| 04/28/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $65.26 | General |
| Category: Insulin Pump | ||||||
| 04/01/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $34.48 | General |
| Category: Insulin Pump | ||||||
| 12/03/2021 | Novo Nordisk Inc | Norditropin (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,755.00 | General |
| Category: Growth Hormone | ||||||
| 12/03/2021 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $48.15 | General |
| Category: Growth Hormone | ||||||
About Robert Levine, MD, PHD
Robert Levine, MD, PHD is a Pediatric Endocrinology healthcare provider based in Mineola, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992824296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Levine, MD, PHD has received a total of $51,581 in payments from pharmaceutical and medical device companies, with $8,870 received in 2024. These payments were reported across 99 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,593).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Mineola, NY
- Active Since 03/28/2007
- Last Updated 02/12/2021
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1992824296
Products in Payments
- Norditropin (Drug) $20,474
- Norditropin (Biological) $12,406
- Sogroya (Biological) $6,554
- Skytrofa (Drug) $5,717
- Dexcom CGM (Device) $3,258
- t-slim insulin pump (Device) $1,803
- Minimed 670G System (Device) $262.20
- AMZEEQ (Drug) $187.49
- Omnipod (Device) $183.43
- ALDURAZYME (Drug) $125.00
- SKYTROFA (Drug) $125.00
- t:slim X2 insulin pump (Device) $122.19
- ZILXI (Drug) $119.43
- iLet Bionic Pancreas (Device) $108.08
- FreeStyle Lite system (Device) $23.75
- BASAGLAR (Drug) $22.92
- ARAZLO (Drug) $19.94
- HUMALOG (Drug) $19.46
- Kanuma (Drug) $18.34
- LUPRON DEPOT (Drug) $17.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Mineola
Paul Saenger, Md, MD
Pediatric Endocrinology — Payments: $313,056
Pediatric Endocrinology $313,056
Mariano Castro-Magana, M.d, M.D
Pediatric Endocrinology — Payments: $54,765
Pediatric Endocrinology $54,765
Siham Accacha, M.d, M.D
Pediatric Endocrinology — Payments: $21,590
Pediatric Endocrinology $21,590
Dr. Liana Gabriel, D.o, D.O
Pediatric Endocrinology — Payments: $599.03
Pediatric Endocrinology $599.03